MacroGenics Announces TAMARACK Phase 2 Data Presentation at ESMO Congress 2024
MacroGenics to present Phase 2 data of vobramitamab duocarmazine in mCRPC at ESMO Congress on Sept. 15, 2024, with a conference call on Sept. 16, 2024.
Highlighted Terms
Related News
MacroGenics to present Phase 2 TAMARACK data on vobramitamab duocarmazine for mCRPC at ESMO Congress 2024, with a conference call scheduled for September 16, 2024.
MacroGenics to present Phase 2 data of vobramitamab duocarmazine in mCRPC at ESMO Congress on Sept 15, 2024, followed by an investor call on Sept 16, 2024.
MacroGenics to present Phase 2 data of vobramitamab duocarmazine in mCRPC at ESMO Congress in Barcelona, with a poster available on Sept 15, 2024, and a conference call on Sept 16, 2024.
MacroGenics to present Phase 2 data of vobramitamab duocarmazine in mCRPC at ESMO Congress on Sept. 15, 2024, with a conference call on Sept. 16, 2024.